You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Type B Insulin Resistance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, Insulin Resistance, Diabetes Trial in Cairo (High intensity interval training, moderate intensity aerobic

Recruiting
  • Diabetes Mellitus, Type 2
  • Insulin Resistance, Diabetes
  • High intensity interval training
  • moderate intensity aerobic exercise
  • Cairo, Egypt
  • +3 more
Jun 3, 2023

Insulin Resistance - Type A, Insulin Resistance - Type B, Lipoatrophic Diabetes Trial in Japan (Empagliflozin Tablets)

Active, not recruiting
  • Insulin Resistance - Type A
  • +3 more
  • Empagliflozin Tablets
  • Kobe, Hyogo, Japan
  • +4 more
Jun 2, 2021

Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)

Not yet recruiting
  • Type 2 Diabetes
  • NAFLD
  • Drinking powder supplement
  • (no location specified)
Dec 8, 2022

Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Pioglitazone 30 mg
  • Placebo
  • Buffalo, New York
    Diabetes and Endocrinology Research Center of WNY
Oct 26, 2022

Behind Severe Insulin Resistance During Pregnancy in Glucose

Recruiting
  • Diabetes Mellitus, Type 2
  • +6 more
  • No interventions
  • Aarhus, Aarhus N, Denmark
  • +1 more
Nov 22, 2022

Mild Cognitive Impairment, Insulin Resistance, Diabetes, Type 2 Trial in Singapore (Metformin, Intensive Lifestyle Intervention,

Terminated
  • Mild Cognitive Impairment
  • +2 more
  • Singapore, Singapore
    SingHealth Polyclinics - Marine Parade Polyclinic
Jan 9, 2023

Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

Not yet recruiting
  • Central Insulin Resistance
  • +2 more
  • Human nasal insulin
  • Placebo
  • (no location specified)
May 12, 2023

Insulin Resistance - Type A, Insulin Resistance - Type B, Lipoatrophic Diabetes Trial in Japan (Empagliflozin Tablets)

Active, not recruiting
  • Insulin Resistance - Type A
  • +3 more
  • Empagliflozin Tablets
  • Kobe, Hyogo, Japan
  • +4 more
Mar 1, 2021

Type2 Diabetes, Insulin Resistance Trial in Odense (Acute exercise)

Completed
  • Type2 Diabetes
  • Insulin Resistance
  • High intensity interval training
  • Odense, Denmark
    Department of Endocrinology, Odense University Hospital
Aug 31, 2022

Type 1 Diabetes Trial in Pamplona (Diactive-1 application)

Recruiting
  • Type 1 Diabetes
  • Diactive-1 application
  • Pamplona, Navarra, Spain
  • +1 more
Sep 20, 2023

Diabetes, Type 2, Diabetes Type 2 in Obese Trial in Washington (low-fat vegan diet)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus Type 2 in Obese
  • low-fat vegan diet
  • Washington, District of Columbia
    Physicians Committee for Responsible Medicine
Oct 31, 2023

Type2 Diabetes, Obesity, Insulin Resistance Trial in Kyiv, Lviv (Probiotic, Placebo)

Completed
  • Type2 Diabetes
  • +3 more
  • Probiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 10, 2023

Weight Loss, Metabolic Syndrome, Diabetes, Type 2 Trial in Palo Alto (Continuous Glucose Monitor Device)

Recruiting
  • Weight Loss
  • +6 more
  • Continuous Glucose Monitor Device
  • Palo Alto, California
    Signos
May 24, 2023

Obesity, Obesity, Abdominal, Insulin Resistance Trial in Kyiv, Lviv (Postbiotic, Placebo)

Recruiting
  • Obesity
  • +5 more
  • Postbiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 14, 2023

Diabete Type 2 Trial in Cairo (aerobic exercises, resistance exercises)

Active, not recruiting
  • Diabete Type 2
  • aerobic exercises
  • resistance exercises
  • Cairo, Gesr Elsuez, Egypt
    Egyptian Chineese University
Apr 26, 2023

Diabetes in Adolescents

Recruiting
  • Type 2 Diabetes
  • +4 more
    • Ann Arbor, Michigan
      University of Michigan
    Aug 17, 2023

    Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg

    Not yet recruiting
    • Type2diabetes
    • Insulin Resistance
    • (no location specified)
    Oct 20, 2022

    T1D, Metabolic Syndrome and Insulin Resistance

    Completed
    • Type 1 Diabetes
    • +2 more
      • Villahermosa, Tabasco, Mexico
        Isela Esther Juarez Rojop
      Aug 13, 2022

      Insulin Resistance, Lipohypertrophy Trial (Embrace Dressing)

      Not yet recruiting
      • Insulin Resistance
      • Lipohypertrophy
      • Embrace Dressing
      • (no location specified)
      Sep 11, 2023

      Obesity, Pre Diabetes, Diabetes, Type 2 Trial in Hattiesburg (Ketone Ester Supplement, Placebo)

      Recruiting
      • Obesity
      • +3 more
      • Ketone Ester Supplement
      • Placebo
      • Hattiesburg, Mississippi
        University of Southern Mississippi - School of Kinesiology and N
      Dec 6, 2022

      Type2 Diabetes Trial in Jakarta (Vitamin D 5000 IU, Placebo)

      Active, not recruiting
      • Type2 Diabetes Mellitus
      • Vitamin D 5000 IU
      • Placebo
      • Jakarta, DKI Jakarta, Indonesia
        Community Health Centers Kecamatan Mampang Prapatan
      Oct 24, 2022

      Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases Trial in Aurora (Metformin Hcl 1000Mg Tab, Aminohippurate

      Recruiting
      • Type 1 Diabetes
      • +4 more
      • Metformin Hcl 1000Mg Tab
      • +3 more
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Jul 28, 2022

      Insulin Resistance, Type 2 Diabetes Trial in Amsterdam (functional MRI)

      Not yet recruiting
      • Insulin Resistance
      • Type 2 Diabetes
      • functional MRI
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam University Medical Centers, location AMC
      Aug 8, 2022

      Insulin Resistance, Diabetes Trial in Baton Rouge (exercise)

      Recruiting
      • Insulin Resistance, Diabetes
      • exercise
      • Baton Rouge, Louisiana
        Pennington Biomedical Research Center
      Sep 7, 2022

      Visceral Fat in type2diabetic Patients and Its Relation to

      Enrolling by invitation
      • Visceral Fat
      • Insulin Resistance
        • Sohag, Egypt
          Mahmoud Soliman
        Oct 31, 2023